争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 2 条
2022
Impossible Foods就汉堡专利起诉Motif Foodworks
提起诉讼
Impossible Foods在特拉华州联邦法院起诉Motif Foodworks，指称Motif在植物牛肉中使用血红素侵犯其专利。Motif称该诉讼毫无依据并表示将抗辩；来源报道的是指控，并未提及法院裁定。
品牌回应
否认 — Motif Foodworks
A Motif spokesperson called the lawsuit “nothing more than a baseless attempt by Impossible Foods to stifle competition” and said it would fight the claims.
来源摘录
The lawsuit filed in Delaware federal court said Motif, a spinoff of biotech company Ginkgo Bioworks, infringes an Impossible Foods patent by using the protein molecule heme in its plant-based beef.
Meatless burger maker Impossible Foods sued competitor Motif Foodworks on Wednesday, accusing the startup of copying its technology for imitating the taste of real meat.
A Motif spokesperson called the lawsuit “nothing more than a baseless attempt by Impossible Foods to stifle competition” and said it would fight the claims.
2019
大豆血红蛋白安全性与标签问题引发公众审视
该公司用于制造血红素的大豆血红蛋白系通过基因工程获得，其使用引发了批评与监管讨论，涉及安全审查、标签标注、过敏原以及植物来源成分与最终植物基产品之间的区分等问题。FDA 对相关“一般认为安全”（GRAS）通知作出了“无问题”答复，但倡导团体与评论人士之间的争论仍在继续。